Clinical Trial Update: Leica Microsystems Sponsored PMCF Study to Collect and Confirm Clinical Data on the Performance of the GLOW400 Device When Used in Accordance With Its Intended Use

View source ↗

Summary

Leica Microsystems has initiated a post-market clinical follow-up study to collect data on the performance of the GLOW400 device when used as intended in glioma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Glioma

Snippet

Sponsor: Leica Microsystems (Schweiz) AG | Conditions: Suspected Grade III and IV Gliomas Requiring Surgical Intervention, Neurosurgical Procedure | Status: NOT_YET_RECRUITING